Hyster-Yale Insider Filing: Colleen Batcheler Receives 963 Shares

Rhea-AI Filing Summary

HYSTER-YALE director Colleen Batcheler reported acquiring 963 Class A Common Stock shares on 10/01/2025 at $0 per share as "Required Shares" under the company's Non-Employee Directors' Equity Compensation Plan. After the award, the reporting person beneficially owns 6,816 shares indirectly, held in trust. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact on 10/02/2025. The disclosure indicates a routine equity grant to a director rather than a market purchase or sale.

Positive

• Director received 963 Class A shares under the Non-Employee Directors' Equity Compensation Plan, aligning management and shareholder interests
• Beneficial ownership increased to 6,816 shares, showing continued stake by a company director

Negative

• None.

Insights

Financial Analyst

TL;DR Routine director equity award of 963 shares increases indirect holdings to 6,816; not a cash purchase or sale.

The transaction is a non-derivative issuance of shares at $0 as required under the company's non-employee director compensation plan. Such awards are common for aligning director incentives with shareholders and typically have limited near-term market impact because they are compensation, not open-market transactions. No changes to outstanding options, indebtedness, or derivative positions are reported.

Corporate Governance Expert

TL;DR A routine required-share issuance to a director under the board compensation plan; governance-alignment signal but not material on its own.

The filing documents compliance with director equity compensation mechanics: shares were awarded as "Required Shares" and are held indirectly in trust. This is standard practice to align non-employee directors with shareholder interests. There is no indication of unusual timing, insider trading, or amendments to governance arrangements in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Batcheler Colleen

(Last) (First) (Middle)

5875 LANDERBROOK DR, SUITE 300

(Street)

CLEVELAND OH 44124

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HYSTER-YALE, INC. [ HY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/01/2025		A(1)		963	A	$0	6,816	I	Shares held in trust for benefit of Reporting Person

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Award-Shares of Class A Common Stock awarded to the Reporting Person as "Required Shares" under the company's Non-Employee Directors' Equity Compensation Plan.

	/s/ Suzanne S. Taylor, attorney-in-fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HYSTER-YALE (HY) Form 4 filed by Colleen Batcheler disclose?

The Form 4 shows Colleen Batcheler was awarded 963 Class A shares on 10/01/2025 as required under the company's Non-Employee Directors' Equity Compensation Plan.

How many HYSTER-YALE shares does the reporting person own after the transaction?

After the award the reporting person beneficially owns 6,816 shares, held indirectly in trust.

Was this Form 4 transaction a market purchase or sale for HY shares?

No. The filing reports an award issuance at $0 (required shares), not an open-market purchase or sale.

When was the Form 4 signed and filed for the HY transaction?

The Form 4 notes the transaction date as 10/01/2025 and bears a signature by attorney-in-fact on 10/02/2025.

Does the Form 4 report any derivative transactions or option exercises for HY?

No. Table II in the Form 4 contains no derivative or option transaction entries.